Forest's Saunders ropes 2nd major sale, boosts personal brand in Actavis deal
This article was originally published in Scrip
Executive Summary
Forest Laboratories president and CEO Brent Saunders has positioned himself as a most-wanted man in the biopharma industry with his second multibillion-dollar sale of a specialty pharmaceutical company in less than a year.